SCHEMBL7066268

SCHEMBL7066268

O=C(O)COc1cc(Cl)ccc1C(=O)NCc1cc(F)cc(C(F)(F)F)c1

nearest known ligand 0.62

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 11/20 0.62
AKR1B10 O60218 1/20 0.58
P2RX1 P51575 1/20 0.55
TMPRSS4 Q9NRS4 1/20 0.55
LMNA P02545 1/20 0.48
HPGD P15428 1/20 0.48
PTGDR2 Q9Y5Y4 2/20 0.45
PTGER4 P35408 1/20 0.44
PPARG P37231 1/20 0.43
PPARD Q03181 1/20 0.43
PPARA Q07869 1/20 0.43
CETP P11597 1/20 0.43
AKR1C3 P42330 1/20 0.43
DDR1 Q08345 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7059962 0.94 AKR1B1 (0.67) AKR1B1AKR1B10P2RX1TMPRSS4LMNA
SCHEMBL14447219 0.90 AKR1B1 (0.71) AKR1B1AKR1B10LMNAPTGDR2PTGER4
SCHEMBL7063092 0.87 AKR1B1 (0.67) AKR1B1AKR1B10LMNAHPGDPTGDR2
SCHEMBL7066939 0.83 AKR1B1 (0.71) AKR1B1AKR1B10LMNAHPGDPTGDR2
SCHEMBL7064934 0.81 AKR1B1 (0.86) AKR1B1AKR1B10HPGDPTGER4AKR1C3
SCHEMBL5470955 0.80 AKR1B1 (0.80) AKR1B1AKR1B10LMNAHPGDPTGDR2
SCHEMBL7063237 0.80 AKR1B1 (0.72) AKR1B1AKR1B10HPGDPTGER4PPARG
SCHEMBL13812913 0.79 TMPRSS4 (0.86) P2RX1TMPRSS4LMNAHPGDDDR1
SCHEMBL7611075 0.78 P2RX1 (0.64) AKR1B1P2RX1TMPRSS4LMNAHPGD
SCHEMBL7064945 0.78 AKR1B1 (0.69) AKR1B1AKR1B10LMNAAKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030036558-A1 Substituted phenoxyacetic acids THE INSTITUTES OF PHARMACEUTICAL DISCOVERY LLC. 2003-02-20 US claimed
JP-2003503381-A 2003-01-28 JP claimed
US-6420426-B1 USED TO TREAT COMPLICATIONS FROM DIABETES MELLITUS THE INSTITUTE FOR PHARMACEUTICAL DISCOVERY LLC 2002-07-16 US claimed
EP-1198451-A2 SUBSTITUTED PHENOXYACETIC ACIDS The Institutes for Pharmaceutical Discovery, LLC (US) 2002-04-24 EP claimed
WO-2001000566-A2 SUBSTITUTED PHENOXYACETIC ACIDS THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY, LLC (US) 2001-01-04 WO claimed
US-20070161631-A1 Substituted Phenoxyacetic Acids PHARMACIA & UPJOHN COMPANY 2007-07-12 US disclosed
US-20070161631-A1 Substituted Phenoxyacetic Acids PHARMACIA & UPJOHN COMPANY 2007-07-12 US disclosed
US-7189749-B2 Substituted phenoxyacetic acids THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY LLC (US) 2007-03-13 US disclosed
US-7189749-B2 Substituted phenoxyacetic acids THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY LLC (US) 2007-03-13 US disclosed
US-20030036558-A1 Substituted phenoxyacetic acids THE INSTITUTES OF PHARMACEUTICAL DISCOVERY LLC. 2003-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161631-A1 Substituted Phenoxyacetic Acids SLC5A2, GPR119, SLC5A1 AKR1B1 708/4885AKR1B10 1623/4885P2RX1 1667/4885
US-20030036558-A1 Substituted phenoxyacetic acids SLC5A2, GPR119, SLC5A1 AKR1B1 708/4885AKR1B10 1623/4885P2RX1 1667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.